Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice.
- 1 December 2013
- journal article
- Vol. 33 (12) , 5261-5271
Abstract
Soluble epoxide hydrolase (sEH) hydrolyses/inactivates anti-inflammatory epoxyeicosatrienoic acids (EETs) to their corresponding diols, and targeting sEH leads to strong anti-inflammatory effects. In the present study, using a tissue microarray and immunohistochemical approach, a significant increase of sEH expression was identified in ulcerative colitis (UC)-associated dysplasia and adenocarcinoma. The effects of deficiency in the sEH gene were determined on dextran sulfate sodium (DSS) colitis-induced carcinogenesis. The effects of EETs on lipopolysaccharide (LPS)-activated macrophages were analyzed in vitro. With extensive histopathological and immunohistochemical analyses, compared to wild-type mice, sEH(-/-) mice exhibited a significant decrease in tumor incidence (13/20 vs. 6/19, p<0.05) and a markedly reduced average tumor size (59.62±20.91 mm(3) vs. 22.42±11.22 mm(3)), and a significant number of pre-cancerous dysplasia (3±1.18 vs. 2±0.83, p<0.01). The inflammatory activity, as measured by the extent/proportion of erosion/ulceration/dense lymphoplasmacytosis (called active colitis index) in the colon, was significantly lower in sEH(-/-) mice (44.7%±24.9% vs. 20.2%±16.2%, p<0.01). The quantitative polymerase chain reaction (qPCR) assays demonstrated significantly low levels of cytokines/chemokines including monocyte chemoattractant protein (MCP-1), inducible nitric oxide synthase (iNOS), vasopressin-activated calcium-mobilizing (VCAM-1), interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). In vitro, LPS-activated macrophages treated with 14,15-EET showed a significant reduction of LPS-triggered IL-1β and TNF-α expression. Eicosanoic acid metabolic profiling revealed a significant increase of the ratios of EETs/ dihydroeicosatrienoic acids (DHETs) and epoxyoctadecennoic acid/dihydroxyoctadecenoic acid (EpOMEs/DiHOMEs). These results indicate that sEH plays an important role in the development of colitis and in inducing carcinogenesis.Keywords
This publication has 40 references indexed in Scilit:
- Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort StudiesClinical Gastroenterology and Hepatology, 2012
- Reduction of inflammatory bowel disease‐induced tumor development in IL‐10 knockout mice with soluble epoxide hydrolase gene deficiencyMolecular Carcinogenesis, 2012
- Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesisInflammatory Bowel Diseases, 2011
- The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammationJournal of Internal Medicine, 2008
- Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitisJournal of Clinical Investigation, 2008
- Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted MiceJournal of Biological Chemistry, 2007
- Peptidyl-urea based inhibitors of soluble epoxide hydrolasesBioorganic & Medicinal Chemistry Letters, 2006
- Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences, 2006
- Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compoundsCarcinogenesis, 2006
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisGastroenterology, 2004